ARTH | Arch Therapeutics’ AC5 Could Be Of Great Use Today

ARTH Stock, OTC ARTH, Arch Therapeutics Inc., OncoSec Medical Inc.,ONCS,Rather appropriately, the penny stock of Arch Therapeutics, Inc. (ARTH) is one of the few winners thus far on the OTC Markets. While almost all of the top traded stocks are in the red, with Prince Mexico S.A, Inc. (LUVE) and Xumanii (XUII) bleeding profusely, traders are hopping onto the ARTH stock bus today rather heavily in anticipation of a burst past $1. Developing liquid polymers containing tiny peptides intended to form gel-like barriers over surgical wounds to stop or control bleeding, no formal PR has been issued to date which means that the VIP tickets for this ride are going fast.

Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!

ARTH Stock Quote

Market Cap: 37.24M
Last: 0.85 ▲ +0.10 (+13.33%)
Volume: 501,197
Dollar Volume: $401,962
Open: 0.75
High: 0.88
Low: 0.75
Trades: 210
Authorized: 300,000,000
Issued and Outstanding: 43,560,000
1st Resistance Point: 0.9033
2nd Resistance Point: 1.0567

Looking for Hot Penny Stocks?
here To Receive FREE Penny Stock Alerts

For the most part, bandages should have been issued to traders prior to today’s open just like the White T-Shirts were handed out to all of us who attended one of the most epic games in NBA Finals history last night. If you’re in LUVE stock or didn’t know that Victory Mark was coming out with a new pick tomorrow which will surely effect the chances of XUII stock ever seeing green until it hits under 0.10, wound care is what your portfolio is looking for and ARTH stock has the cure.

Linked on our initial coverage when the share price was at 0.79, Arch Therapeutics and the involvement of Avtar Dhillon, M.D. can be translated as “money in the bank!” No PR has yet to be released on ARTH and their intentions to be able to help prevent patients from bleeding out on the surgical table with their AC5™, the bus is filling up and once your sent to the back of it, its gonna be that much harder to have a good view as the bus climbs over the $1 hump in the coming weeks while on its journey to beat the high set by Stevia First ($3.28)

With a similar share structure and a top notch track record with throwing up triple digit gains from STVF and ONCS, you would have to have a hole in your head if you weren’t already tracking or preparing to track the developments of ARTH.

About ARTH Stock

Arch Therapeutics, Inc. is a medical device company focused on developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding.

Click here to view the SEC filings for ARTH.
Click here to view the website for Arch Therapeutics.

Last 5 Trading Sessions:

Date Last Change % Change Volume
06/19/13 0.8600 +0.1100 +14.67% 501,197
06/18/13 0.7500 -0.0200 -2.60% 3,823,400
06/17/13 0.7700 -0.0900 -10.47% 1,928,400
06/14/13 0.8600 +0.0100 +1.18% 86,000
06/13/13 0.8500 -0.1000 -10.53% 7,200


facebookTwitterStay Connected With Us: 

Bottom Line:

The only thing hotter than this penny stock right now is a Miami Heat fan after last night’s 1 point overtime win (guilty as charged). It’s still very early, but looking at the share structure and the connectivity to a 2012 triple bagger in STVF, ARTH stock is a required addition to the watch list for anyone looking to avoid getting duped by tomorrow’s pick from Victory Mark.

* Email

Here is your opportunity to subscribe to the Most Read Penny Stock Newsletter

If You Can’t Make Money With Us, You Shouldn’t Be Trading Penny Stocks

(We are 100% Anti-Spam and will never rent or sell your information)

Last updated by at .

  Recent Penny Stock News